acne

JDD February 2024 Issue Highlights
psoriasisExplore the February 2024 issue of the Journal of Drugs in Dermatology! Discover groundbreaking research on topics such as novel treatments for melasma, advancements in psoriasis management, gene expression profile (GEP) testing for squamous cell carcinoma, pediatric vitiligo, and many more! Stay ahead of the curve with the latest insights from leading dermatology experts. Straight from the Editor …
psoriasis
JDD December 2023 Issue Highlights
Welcome to the December 2023 issue of the Journal of Drugs in Dermatology (JDD), where cutting-edge research and advancements in the field of dermatology take center stage. This issue brings together a diverse array of original articles, case reports, brief communications, and letters to the editor and delves into the latest developments, therapeutic breakthroughs, and cl …
JDD October 2023 Issue Highlights | Special Topic: Atopic Dermatitis
atopic dermatitisThe October 2023 issue of the Journal of Drugs in Dermatology (JDD) focuses on atopic dermatitis and features mix of original articles, letters to the editor, and case reports. Among many of the topics explored in this issue are statins for treating actinic porokeratosis, ant venom-based ceramide therapy, the psychosocial burden of skin disease among skin of color consumers, treatment of lichen pl …
atopic dermatitis
Patient Buzz Series: At-Home Skincare Devices
skincare devicesAt-home skincare devices are now widely available to consumers, from handheld light wands for acne and wrinkles to laser hair removal devices. While no at-home device can fully mimic the benefits of in-office treatments, dermatologists spoke with Everyday Health and HuffPost about which at-home devices are worth consideration. Dermatologist Dr. Rachel Westbay told HuffPost that consumers can us …
skincare devices
Baricitinib Therapeutic Cheat Sheet
BaricitinibBaricitinib (Olumiant®) is a once daily oral medication recently FDA approved for severe alopecia areata, which is defined as having a Severity of Alopecia Tool (SALT) score of 50 or higher.1 JAK inhibitors are a relatively new class of drug demonstrating efficacy and safety in a range of inflammatory skin disorders. Emerging studies have highlighted baricitinib’s effectiveness for conditions l …
Baricitinib